Low-molecular weight dextran in treatment of shock not associated with primary loss of systemic fluids.
D000707:Anaphylaxis / Q000150:complications; D003911:Dextrans / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D009203:Myocardial Infarction / Q000150:complications; D009638:Norepinephrine / Q000627:therapeutic use; D012769:Shock / Q000628:therapy*; D012772:Shock, Septic / Q000628:therapy; D013997:Time Factors
D003911:Dextrans; D009638:Norepinephrine